Drugs / Sulperazon
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT04370145 | May → Oct 2021 | cholangitis | Tongji Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05052619 | Jul 2021 → Jul 2023 | — | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sulperazon | “Treat patients in this group with advanced preventive usage of antibiocs: Sulperazon 3g q8h, in postoperative days 1-5.” NCT05052619 ↗ |
| Route | Intravenous | “Sulperazon, iv.,drip,100mg/Kg,Bid” NCT04370145 ↗ |